Literature DB >> 15731091

Production of a proteolytically active protein, chlamydial protease/proteasome-like activity factor, by five different Chlamydia species.

Feng Dong1, Youmin Zhong, Bernard Arulanandam, Guangming Zhong.   

Abstract

We have previously identified a chlamydial protein, chlamydial protease/proteasome-like activity factor (CPAF), for degrading host transcription factors in cells infected with the human chlamydial species Chlamydia trachomatis or Chlamydia pneumoniae. We now report that functional CPAF was also produced during infection with the species Chlamydia muridarum, Chlamydia psittaci, and Chlamydia caviae, which primarily infect nonhuman hosts.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15731091      PMCID： PMC1064953          DOI： 10.1128/IAI.73.3.1868-1872.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  29 in total

1.  Cleavage of host keratin 8 by a Chlamydia-secreted protease.

Authors:  Feng Dong; Heng Su; Yanqing Huang; Youmin Zhong; Guangming Zhong
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

2.  Genome sequences of Chlamydia trachomatis MoPn and Chlamydia pneumoniae AR39.

Authors:  T D Read; R C Brunham; C Shen; S R Gill; J F Heidelberg; O White; E K Hickey; J Peterson; T Utterback; K Berry; S Bass; K Linher; J Weidman; H Khouri; B Craven; C Bowman; R Dodson; M Gwinn; W Nelson; R DeBoy; J Kolonay; G McClarty; S L Salzberg; J Eisen; C M Fraser
Journal:  Nucleic Acids Res       Date:  2000-03-15       Impact factor: 16.971

3.  Chlamydia pneumoniae infection significantly exacerbates aortic atherosclerosis in an LDLR-/- mouse model within six months.

Authors:  L Liu; H Hu; H Ji; A D Murdin; G N Pierce; G Zhong
Journal:  Mol Cell Biochem       Date:  2000-12       Impact factor: 3.396

4.  Immunization with the Chlamydia trachomatis mouse pneumonitis major outer membrane protein can elicit a protective immune response against a genital challenge.

Authors:  S Pal; I Theodor; E M Peterson; L M de la Maza
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

5.  Persistent Chlamydia trachomatis infections resist apoptotic stimuli.

Authors:  D Dean; V C Powers
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

6.  Chlamydia pneumoniae infection accelerates hyperlipidemia induced atherosclerotic lesion development in C57BL/6J mice.

Authors:  E Blessing; L A Campbell; M E Rosenfeld; N Chough; C C Kuo
Journal:  Atherosclerosis       Date:  2001-09       Impact factor: 5.162

7.  The atherogenic effects of chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniae.

Authors:  H Hu; G N Pierce; G Zhong
Journal:  J Clin Invest       Date:  1999-03       Impact factor: 14.808

8.  Cleavage-dependent activation of a chlamydia-secreted protease.

Authors:  Feng Dong; Mustak Pirbhai; Youmin Zhong; Guangming Zhong
Journal:  Mol Microbiol       Date:  2004-06       Impact factor: 3.501

9.  Degradation of transcription factor RFX5 during the inhibition of both constitutive and interferon gamma-inducible major histocompatibility complex class I expression in chlamydia-infected cells.

Authors:  G Zhong; L Liu; T Fan; P Fan; H Ji
Journal:  J Exp Med       Date:  2000-05-01       Impact factor: 14.307

10.  Identification of a chlamydial protease-like activity factor responsible for the degradation of host transcription factors.

Authors:  G Zhong; P Fan; H Ji; F Dong; Y Huang
Journal:  J Exp Med       Date:  2001-04-16       Impact factor: 14.307
View more
  28 in total

1.  Immunization with a combination of integral chlamydial antigens and a defined secreted protein induces robust immunity against genital chlamydial challenge.

Authors:  Weidang Li; Ashlesh K Murthy; M Neal Guentzel; James P Chambers; Thomas G Forsthuber; J Seshu; Guangming Zhong; Bernard P Arulanandam
Journal:  Infect Immun       Date:  2010-07-06       Impact factor: 3.441

2.  Intranasal vaccination with a secreted chlamydial protein enhances resolution of genital Chlamydia muridarum infection, protects against oviduct pathology, and is highly dependent upon endogenous gamma interferon production.

Authors:  Ashlesh K Murthy; James P Chambers; Patricia A Meier; Guangming Zhong; Bernard P Arulanandam
Journal:  Infect Immun       Date:  2006-11-21       Impact factor: 3.441

3.  The protective efficacy of chlamydial protease-like activity factor vaccination is dependent upon CD4+ T cells.

Authors:  Cathi Murphey; Ashlesh K Murthy; Patricia A Meier; M Neal Guentzel; Guangming Zhong; Bernard P Arulanandam
Journal:  Cell Immunol       Date:  2006-11-20       Impact factor: 4.868

Review 4.  Molecular mechanisms of host-pathogen interactions and their potential for the discovery of new drug targets.

Authors:  Volker Briken
Journal:  Curr Drug Targets       Date:  2008-02       Impact factor: 3.465

5.  A chlamydial type III-secreted effector protein (Tarp) is predominantly recognized by antibodies from humans infected with Chlamydia trachomatis and induces protective immunity against upper genital tract pathologies in mice.

Authors:  Jie Wang; Lili Chen; Fan Chen; Xiaoyun Zhang; Yingqian Zhang; Joel Baseman; Sondra Perdue; I-Tien Yeh; Rochelle Shain; Martin Holland; Robin Bailey; David Mabey; Ping Yu; Guangming Zhong
Journal:  Vaccine       Date:  2009-03-10       Impact factor: 3.641

6.  Chlamydia trachomatis inclusions induce asymmetric cleavage furrow formation and ingression failure in host cells.

Authors:  He Song Sun; Andrew Wilde; Rene E Harrison
Journal:  Mol Cell Biol       Date:  2011-10-03       Impact factor: 4.272

7.  Preparation and evaluation of monoclonal antibodies against chlamydial protease-like activity factor to detect Chlamydia pneumoniae antigen in early pediatric pneumonia.

Authors:  J Zheng; T Ding; Z Chen; H Fang; H Li; H Lu; Y Wu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-03-12       Impact factor: 3.267

8.  Heat denatured enzymatically inactive recombinant chlamydial protease-like activity factor induces robust protective immunity against genital chlamydial challenge.

Authors:  Bharat K R Chaganty; Ashlesh K Murthy; Shankar J Evani; Weidang Li; M Neal Guentzel; James P Chambers; Guangming Zhong; Bernard P Arulanandam
Journal:  Vaccine       Date:  2010-01-05       Impact factor: 3.641

9.  Identifying catalytic residues in CPAF, a Chlamydia-secreted protease.

Authors:  Ding Chen; Jijie Chai; P John Hart; Guangming Zhong
Journal:  Arch Biochem Biophys       Date:  2009-05-01       Impact factor: 4.013

10.  Caspase-1 contributes to Chlamydia trachomatis-induced upper urogenital tract inflammatory pathologies without affecting the course of infection.

Authors:  Wen Cheng; Pooja Shivshankar; Zhongyu Li; Lili Chen; I-Tien Yeh; Guangming Zhong
Journal:  Infect Immun       Date:  2007-11-19       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.